Home/Products /ceftazidime-2gm-avibactam-0-5gm-10-10

Ceftazidime 2gm + Avibactam 0.5gm Injection PCD Company in Maharashtra

Name: Dimezeft 2.5 Injection (Ceftazidime (2gm) + Avibactam (0.5gm))
Brand: Dimezeft 2.5 Injection
Rating: 4.8 (150 reviews)

Ceftazidime + Avibactam 2.5gm Injection Franchise Supplier in Karnataka

Ceftazidime Avibactam 2.5g Injection Manufacturer in Himachal Pradesh

Best PCD Pharma for Ceftazidime + Avibactam Injection in Gujarat

Ceftazidime 2g + Avibactam 0.5g Injection Third Party Manufacturer in Tamil Nadu

Ceftazidime + Avibactam 2.5gm Injection Exporter from India

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Ceftazidime (2gm) + Avibactam (0.5gm) Injection in PCD Pharma Franchise at Best Price

Ceftazidime (2gm) + Avibactam (0.5gm) Injection in Third Party Manufacturing at Competitive Price

Ceftazidime (2gm) + Avibactam (0.5gm) Injection from Best Pharma Exporter at Best Price

Ceftazidime (2gm) + Avibactam (0.5gm) Injection by Top Pharma Company in India at Competitive Price

Dimezeft 2.5 Injection in Anti-Infective Franchise

Dimezeft 2.5 Injection

Composition : Ceftazidime (2gm) + Avibactam (0.5gm) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 2.5gm

Price : ₹1/-

Please Contact For Best Price

Dimezeft 2.5 Injection contains a potent combination of Ceftazidime (2gm) and Avibactam (0.5gm). Ceftazidime is a third-generation cephalosporin antibiotic with broad-spectrum activity against many Gram-negative and some Gram-positive bacteria. Avibactam is a non-beta-lactam beta-lactamase inhibitor that protects Ceftazidime from degradation by certain resistant bacteria, thereby significantly enhancing its effectiveness.

This combination is especially effective against multi-drug resistant (MDR) infections, including those caused by extended-spectrum beta-lactamase (ESBL) and carbapenem-resistant strains.

It helps in the treatment of complicated intra-abdominal infections, complicated urinary tract infections (including pyelonephritis), hospital-acquired pneumonia (including ventilator-associated pneumonia), and other life-threatening drug-resistant bacterial infections.

About the Product

This combination is especially effective against multi-drug resistant (MDR) infections, including those caused by extended-spectrum beta-lactamase (ESBL) and carbapenem-resistant strains.

Common side effects may include nausea, vomiting, diarrhea, constipation, headache, and pain at the injection site. Rare but serious effects may include allergic reactions, changes in liver or kidney function, or Clostridium difficile-associated diarrhea.

Indicated for the treatment of serious and drug-resistant bacterial infections, especially in hospital settings. Effective in treating infections of the lungs, abdomen, urinary tract, and bloodstream caused by resistant organisms.

This injection is intended for use only under strict medical supervision, typically in a hospital. Inform your doctor of any known allergies, especially to cephalosporins or penicillins. Dosage adjustments may be needed in patients with renal impairment. Always complete the full course of therapy.

Store below 25°C in a dry place. Protect from direct light. Once reconstituted, use immediately or as per healthcare provider instructions. Keep out of reach of children.